Status:
COMPLETED
Biomarkers Correlation With Volemia
Lead Sponsor:
ThermoFisher Scientific Brahms Biomarkers France
Conditions:
Cerebral Hemorrhage
Head Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the Biomarkers (pro adrenomedullin (MR proADM), pro arginin vasopressin (CT proAVP), pro atrial natriuretic peptid (MR proANP), Pro Endothelin) change...
Eligibility Criteria
Inclusion
- 20 Cerebral Hemorrhage
- 20 Head Injury
- 20 post surgery non traumatic non neuro
- 20 Polytrauma patients
Exclusion
- Heart failure NYHA III or IV
- Renal insufficiency creatinin clearance \< 30 ml/mn
- age \< 18 Y
- Pregnancy
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT01858675
Start Date
March 1 2012
End Date
December 1 2014
Last Update
December 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Bicêtre
Le Krémilin Bicêtre, Île-de-France Region, France, 94 275